JFR 2017From Friday the 13th to Monday the 16th
of OctoberParis Congress CenterBooth 217
SuperSonic Imagine will be making a splash at
JFR this year with several key events:
- A symposium on the clinical
benefits of new imaging modalities in daily practice: breast, liver
and prostate
- Flash demonstrations of
multi-parameter imaging of the liver with elastography, Doppler and
contrast in the Ultrasound Village
- Reception and demonstrations at Booth
217, Level 2
Regulatory News:
SuperSonic Imagine (Paris:SSI) (Euronext: SSI (FR0010526814,
PEA-PME eligible), a company specializing in medical imaging using
ultrasound (ultrasonography), for the first time at an
international radiology conference, will introduce its the new
version of its premium ultrasound system, Aixplorer® Ultimate.
Attendees are invited to visit SuperSonic Imagine’s booth #217
during JFR.
“We are very proud to introduce Aixplorer Ultimate to
radiologists and physicians with a international premier at JFR. We
are working closely with the scientific community so that our
technology will become a standard in expert imaging of diseases of
the breast and liver to improve the treatment of patients diagnosed
with cancer or chronic liver diseases such as fibrosis or steatosis
(NASH),” said Michèle Lesieur, CEO of SuperSonic
Imagine.
The SuperSonic Imagine technology, whose acquisition frame
rates are 200 times faster than conventional ultrasound
systems, has opened up the possibility of new imaging
modalities which are now in daily use in hospitals and clinics.
Aixplorer® Ultimate is bursting with innovation
thanks to the exclusive UltraFast™ technology.
The Aixplorer Ultimate has a new streamlined look and intuitive
user interface. It incorporates new architecture boasting 4.5 times
more computing power than previous Aixplorer models.
Supersonic Imagine optimizes the development of non-invasive
evaluation tools to evaluate non-alcoholic steatotic hepatitis
(NASH).
Ultimate also incorporates the very latest UltraFast innovation
– Needle PL.U.S – enabling simultaneous visualization of
anatomical structures, biopsy needle and the trajectory with a high
level of precision. These innovations provide fast and reliable
access to diagnostic information, an essential resource for the
diagnosis and assessment of major diseases such as chronic liver
disease, breast and prostate cancers. SuperSonic Imagine provides
physicians an increased reliability of interventional
procedures using ultrasound guidance while improving patient’s
safety and comfort.
Needle PL.U.S. sits alongside other modalities introduced over
the past 8 years by SSI: ShearWave™ Elastography (SWE™),
used to view and measure the stiffness of tissue in real time using
color mapping; UltraFast Doppler, which combines Pulsed
Doppler and Color Doppler in a single sweep; Angio PL.U.S.,
offering unrivalled resolution for imaging micro vascularization in
lesions; and TriVu (B mode + SWE + Color+), a new triplex
modality combining three types of diagnostic information into a
single image.
In the management of breast disease, Aixplorer®
Ultimate helps to improve the identification of malignant or
benign lesions and helps to reduce the number of biopsies.
The advantages of ShearWave Elastography in the diagnosis of
mammary lesions has been demonstrated in more than 100 articles in
peer-reviewed journals, including an international study involving
more than 1,600 patients.1-2 When this technology is combined with
conventional ultrasonography, diagnoses can be more accurate,
significantly reducing the number of false positives, and thus
the number of unnecessary biopsies.
“ShearWave Elastography, integrated with morphological
characteristics, improves the diagnostic performance of
ultrasonography by enhancing the characterisation and boosting the
specificity of mammary lesions. It makes it possible to decrease
unnecessary follow-ups and negative biopsies,” explains Dr
Cohen-Zarade, radiologist at IRP (Paris Radiology Institute).
In the liver, Aixplorer® Ultimate can assess
liver stiffness for the assessment of liver fibrosis severity and
NASH without a biopsy
“Aixplorer is a comprehensive, non-invasive diagnostic tool for
chronic diseases of the liver. It makes it possible both to
quantify liver fibrosis by assessing liver stiffness and projected
changes with ShearWave Elastography and to quantify steatohepatitis
of alcoholic or non-alcoholic origin (NASH) through the hepatorenal
index,” underlines Dr Mona Munteanu, Anti-Fibrosis Diagnosis
Centre, Pitié-Salpêtrière Hospital Group, Paris.
More than 120 international articles agree in demonstrating the
reliability and effectiveness of ShearWave Elastography in this
particular field.
With Aixplorer Ultimate, the most advanced version of its
ultrasonograph, SuperSonic Imagine Research has found a way to
satisfy a wide range of clinical needs among radiologists and
physician to benefit their patients, positioning itself as a major
player in multi-parameter ultrasound imaging.
Dates, times and locations of the SuperSonic Imagine
symposium, workshops and demonstrations
Symposium: Saturday, 14 October
from 12:30 pm to 1:15 pmLocation: Room
342 ASession: New ultrasound imaging
modalities in daily practice: breast, liver and
prostate.Speakers:
- Prof. Christophe Aubé,
Angers: Multimodal ultrasonography: toward the detection of
chronic liver diseases.
- Prof. Jean-Michel Correas,
Paris: Use and benefits of fusion and navigation on the
Aixplorer ultrasonograph for the prostate.
- Dr. Dominique Fournier, Sion,
Switzerland: Lymph node staging in breast cancer: toward 100%
ultrasonography.
Workshop in the official programme:
Saturday, 14 October, 8:45-9:30 am,Location: Room 342BSpeaker:
- Dr. Christophe Tourasse, 'Mammary
ultrasonography: What are the pitfalls? How to distinguish between
benign and malignant. '
Ultrasound Village: For the full
duration of the conference.Flash demonstration: Saturday, 14
October, 10:20-10:35 am, and Monday, 16 October, 11:50 am-12:05
pm
Speaker:
- Dr. Aymeric Guibal, 'Multi-parameter
imaging of the liver: elastography, Doppler and contrast.'
1 ShearWave Elastography for breast masses is highly
reproducible. Cosgrove DO et al. European Radiology2011 Dec 312
Shear-wave Elastography Improves the Specificity of Breast US: The
BE1 Multinational Study of 939 MassesRadiology (2012
Feb;262(2):435-449) by Wendie A. Berg, MD, PhD, et al. Radiology.
2012 Feb;262(2):435-49. doi: 10.1148/radiol.11110640. Eur Radiol.
2012 May; 22(5): 1023–1032.
About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France),
SuperSonic Imagine is a company specializing in medical imaging.
The company designs, develops and markets a revolutionary
ultrasound system, Aixplorer®, with an UltraFast™ platform that can
acquire images 200 times faster than conventional ultrasound
systems. In addition to providing exceptional image quality, this
unique technology is the foundation of several innovations which
have changed the paradigm of ultrasound imaging: ShearWave™
Elastography (SWETM), UltraFast™ Doppler, Angio PL.U.S – Planewave
UltraSensitiveTM Imaging and more recently TriVu. ShearWave
Elastography allows physicians to visualize and analyze the
stiffness of tissue in a real-time, reliable, reproducible and
non-invasive manner. This criteria has become an important
parameter in diagnosing potentially malignant tissue or other
diseased tissue. As of today, over 300 peer-reviewed publications
have demonstrated the value of SWE for the clinical management of
patients with a wide range of diseases. UltraFast Doppler combines
Color Flow Imaging and Pulsed Wave Doppler into one simple exam,
providing physicians with exam results simultaneously and helping
to increase patient throughput. The latest innovation, Angio
PL.U.S, provides a new level of microvascular imaging through
significantly improved color sensitivity and spatial resolution
while maintaining exceptional 2D imaging.
SuperSonic Imagine has been granted regulatory clearances for
the commercialization of Aixplorer in key global markets.
SuperSonic Imagine is a listed company since April 2014 on the
Euronext, symbol SSI. For more information about SuperSonic
Imagine, please go to www.supersonicimagine.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171011005960/en/
SuperSonic ImagineMarketing & CommunicationEmmanuelle
Vella, +33 4 86 79 03
27emmanuelle.vella@supersonicimagine.comorNewCapInvestor
Relations – EUPierre Laurent / Florent Alba, +33 1 44 71 98
55supersonicimagine@newcap.frorFP2COMFlorence Portejoie, +33
6 07 76 82 83fportejoie@fp2com.frorPascale
CommunicationMedia Relations - USAmy Phillips,
+1-412-327-9499amy@pascalecommunications.com
Stage Stores (NYSE:SSI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Stage Stores (NYSE:SSI)
Historical Stock Chart
From Mar 2023 to Mar 2024